In Silico Medicinein Digital Health Research & Innovation
In silico medicine, the use of computer simulation in the diagnosis, treatment, or prevention of a disease, compliments in vivo and in vitro medicine. This synergy between medical informatics, biocomputational modelling, and bioinformatics and its potentially highly transformational impact on healthcare has been promoted by the European Commission since 2001. The European Virtual Physiological Human (VPH) Initiative has spawned collaborative projects across disciplines and with international partners in industry, academia, and healthcare. Decision support systems incorporating personalised and predictive models are developed in order to provide for health forecasting , safer medical operations, the development of personalised treatments, for improved prevention and prediction of disease development, as well as for safer clinical trials and drugs. Medical device testing is another promising application field.
empirica has supported researchers, developers and industry on both sides of the Atlantic through project development, RTD and health policy analysis, roadmapping towards the “Digital Patient”, socio-economic and clinical impact assessment, market exploration, exploitation scenarios and business case development, including identifying core value propositions for stakeholders involved. In silico medicine exhibits a great potential to help address today’s health system challenges through greatly impacting on how medicine is delivered, and gain technologically competitive advantages for Europe, for both its research community and industry.
